Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival

Por Thakur, Satbir, Nabbi, Arash, Klimowicz, Alexander, Riabowol, Karl
Publicado no Mol Cancer (2015)

ING3 promotes prostate cancer growth by activating the androgen receptor

Por Nabbi, Arash, McClurg, Urszula L., Thalappilly, Subhash, Almami, Amal, Mobahat, Mahsa, Bismar, Tarek A., Binda, Olivier, Riabowol, Karl T.
Publicado no BMC Med (2017)

Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer

Por McClurg, Urszula L., Harle, Victoria J., Nabbi, Arash, Batalha-Pereira, Amanda, Walker, Scott, Coffey, Kelly, Gaughan, Luke, McCracken, Stuart RC, Robson, Craig N.
Publicado no Oncotarget (2015)

Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein

Por McClurg, Urszula L, Nabbi, Arash, Ricordel, Charles, Korolchuk, Svitlana, McCracken, Stuart, Heer, Rakesh, Wilson, Laura, Butler, Lisa M, Irving-Hooper, Bronwyn Kate, Pedeux, Rémy, Robson, Craig N, Riabowol, Karl T, Binda, Olivier
Publicado no Br J Cancer (2018)